BERLIN, Germany and BRUSSELS, Belgium, December 09, 2025 / Biotech Newswire / -- ProBioGen and Spica Therapeutics (Spica), a pioneering biotechnology company advancing pathogenic macrophage ...
STRASBOURG, France and BERLIN, Germany, November 05, 2024 / Biotech Newswire / -- Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the ...
Berlin, Germany, and Utrecht, The Netherlands - March 4, 2014 – ProBioGen AG and Merus B.V. today announced that the companies have signed a non-exclusive commercial option and license agreement on ...
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, announced an agreement with Polpharma Biologics, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback